生物技术通讯
生物技術通訊
생물기술통신
LETTERS IN BIOTECHNOLOGY
2015年
2期
219-222
,共4页
冼江%张海燕%王捷%冯玉莉
冼江%張海燕%王捷%馮玉莉
승강%장해연%왕첩%풍옥리
肺腺癌%表皮生长因子受体%基因突变
肺腺癌%錶皮生長因子受體%基因突變
폐선암%표피생장인자수체%기인돌변
lung adenocarcinoma%epidermal growth factor receptor%gene mutation
目的:通过检测肺腺癌组织中表皮生长因子受体(EGFR)基因的突变情况,研究EGFR突变与患者临床特征(性别、年龄和吸烟史)的相关性。方法:收集160例肺腺癌患者术前的石蜡组织标本,提取DNA后用实时定量PCR方法对EGFR基因18~21外显子进行突变检测;对基因突变结果与患者的性别、年龄和吸烟史分别做χ2检验。结果:160例肺腺癌组织标本中,有57例检测到EGFR基因突变,突变率为35.6%,且突变与患者性别、年龄和吸烟史均无显著相关性(P>0.05);57例EGFR基因突变标本中,27例为19外显子缺失,22例为21外显子L858R点突变,这2种突变占总突变类型的85.96%,并且与患者性别、年龄及吸烟史无显著相关性(P>0.05)。结论:EGFR基因在女性不吸烟肺腺癌中有较高的突变率,突变主要集中在19外显子缺失和21外显子L858R点突变,但突变率及突变类型与患者性别、年龄和吸烟史均不相关。
目的:通過檢測肺腺癌組織中錶皮生長因子受體(EGFR)基因的突變情況,研究EGFR突變與患者臨床特徵(性彆、年齡和吸煙史)的相關性。方法:收集160例肺腺癌患者術前的石蠟組織標本,提取DNA後用實時定量PCR方法對EGFR基因18~21外顯子進行突變檢測;對基因突變結果與患者的性彆、年齡和吸煙史分彆做χ2檢驗。結果:160例肺腺癌組織標本中,有57例檢測到EGFR基因突變,突變率為35.6%,且突變與患者性彆、年齡和吸煙史均無顯著相關性(P>0.05);57例EGFR基因突變標本中,27例為19外顯子缺失,22例為21外顯子L858R點突變,這2種突變佔總突變類型的85.96%,併且與患者性彆、年齡及吸煙史無顯著相關性(P>0.05)。結論:EGFR基因在女性不吸煙肺腺癌中有較高的突變率,突變主要集中在19外顯子缺失和21外顯子L858R點突變,但突變率及突變類型與患者性彆、年齡和吸煙史均不相關。
목적:통과검측폐선암조직중표피생장인자수체(EGFR)기인적돌변정황,연구EGFR돌변여환자림상특정(성별、년령화흡연사)적상관성。방법:수집160례폐선암환자술전적석사조직표본,제취DNA후용실시정량PCR방법대EGFR기인18~21외현자진행돌변검측;대기인돌변결과여환자적성별、년령화흡연사분별주χ2검험。결과:160례폐선암조직표본중,유57례검측도EGFR기인돌변,돌변솔위35.6%,차돌변여환자성별、년령화흡연사균무현저상관성(P>0.05);57례EGFR기인돌변표본중,27례위19외현자결실,22례위21외현자L858R점돌변,저2충돌변점총돌변류형적85.96%,병차여환자성별、년령급흡연사무현저상관성(P>0.05)。결론:EGFR기인재녀성불흡연폐선암중유교고적돌변솔,돌변주요집중재19외현자결실화21외현자L858R점돌변,단돌변솔급돌변류형여환자성별、년령화흡연사균불상관。
Objective: To investigate the prevalence of epidermal growth factor receptor(EGFR) gene mutation in Chinese patients with lung adenocarcinoma, as well as the relationships between EGFR gene mutation and clinical features(gender, age, and smoking history) of patients. Methods: 160 formalin-fixed, paraffin-embedded lung ade?nocarcinoma samples were collected before surgical resection, and their genomic DNAs were extracted. EGFR gene mutation within exons 18 to 21 were detected by real-time quantitative PCR, and the relationships between EGFR gene mutation and clinical features of patients were analyzed by chi-squared test. Results: EGFR gene mutation was found in 57 out of 160 lung adenocarcinoma samples, and the mutation frequency was as high as 35.6%. However, EGFR gene mutation was not correlated with gender, age, and smoking history of patients(P>0.05). Fur?ther, exon 19 deletion was found in 27 samples, while L858R mutation in exon 21 was detected in 22 samples. These two types of mutation accounted for 85.96% of total EGFR gene mutation, and was also not correlated with gender, age, and smoking history of patients(P>0.05). Conclusion: EGFR gene is frequently mutated in female non-smoker with lung adenocarcinoma. Exon 19 deletion and L858R mutation in exon 21 are two major types of EGFR gene mutation. However, EGFR gene mutation status(mutation frequency, types) is not significantly correlat?ed with gender, age, and smoking history of patients.